Journalist Matt Schiavenza offers advice to companies looking for ways to get a foothold in Cuba’s emerging domestic market. Businesses face layers of bureaucratic red tape, censorship concerns and meager paychecks. However, the island nation boasts a highly educated workforce that is already proving valuable in the medical and IT fields. For pharmaceutical companies, Cuba could emerge a prime research spot, while tech companies have a large workforce already in place. getAbstract recommends this analysis to business leaders interested in the Cuba’s unique market.
In this summary, you will learn
- Why Cuba’s highly educated workforce could benefit the medical field and IT companies,
- Why a promising lung cancer vaccine could signal an opening for pharmaceutical companies, and
- Why the country could become an IT hub.
About the Author
Matt Schiavenza is a writer and editor based in New York. His articles have been published in The Atlantic, the Daily Beast, Fortune and the New Republic.